Changing the Approach to Anticoagulant Therapy in Older Patients with Multimorbidity Using a Precision Medicine Approach

about

Changing the Approach to Anticoagulant Therapy in Older Patients with Multimorbidity Using a Precision Medicine Approach

Item

http://www.wikidata.org/entity/Q58802818

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Changing the Approach to Antic ...... a Precision Medicine Approach

@en

Changing the Approach to Antic ...... a Precision Medicine Approach

@nl

type

Item

label

Changing the Approach to Antic ...... a Precision Medicine Approach

@en

Changing the Approach to Antic ...... a Precision Medicine Approach

@nl

prefLabel

Changing the Approach to Antic ...... a Precision Medicine Approach

@en

Changing the Approach to Antic ...... a Precision Medicine Approach

@nl

P1476

Changing the Approach to Antic ...... a Precision Medicine Approach

@en

P2093

Leda Marina Pomes

http://www.w3.org/2001/XMLSchema#string

Luana Lionetto

http://www.w3.org/2001/XMLSchema#string

Matilde Capi

http://www.w3.org/2001/XMLSchema#string

Maurizio Simmaco

http://www.w3.org/2001/XMLSchema#string

Valeriano Soldati

http://www.w3.org/2001/XMLSchema#string

Vittoria Polidori

http://www.w3.org/2001/XMLSchema#string

P2860

Number of medications and adverse drug events by unintentional poisoning among older adults in consideration of inappropriate drug use: a Swedish population-based matched case-control study.

Atrial fibrillation: the current epidemic

Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960.

Polypharmacy and Polymorbidity in Older Adults in Brazil: a public health challenge.

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.

Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care.

Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics.

Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

P304

1634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJERPH15081634

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Martelletti

Andrea Negro

Angela Koverech

P577

2018-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30072608

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

6122067

http://www.w3.org/2001/XMLSchema#string